The Motor Neurological Soft Signs (MNSS) in Persons With Schizophrenia
NCT ID: NCT04495998
Last Updated: 2023-06-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
103 participants
INTERVENTIONAL
2017-01-31
2020-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive-motor Dual Task Training in Patients With Multiple Sclerosis
NCT04619953
Upper Limb Function in Mental Health Disorders
NCT06949449
Movement Disorders in Multiple Sclerosis Patients
NCT05973929
Physiology of Weakness in Movement Disorders
NCT00307346
Neurovisual Function in CHARGE Syndrome
NCT05764980
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
It is therefore important to answer the following starting questions:
* How can MNSS be assessed and analysed in the Portuguese population with schizophrenia?
* How does the manifestation of MNSS differ between people with and without schizophrenia?
* Do the MNSS of people with schizophrenia vary according to their functionality level including the following areas of activity (Cognition, Mobility, Self-Care, Interpersonal Relations, Daily Activities and Participation) and their motor experiences?
* How can the information obtained by applying a validated assessment tool for this purpose be made operational as a procedure for psychomotor assessment and intervention with this population?
The following objectives have been defined to answer these questions, which guide the work:
1. Translate, adapt and validate the BMS instrument (Jahn et al., 2006) for the Portuguese population with schizophrenia;
2. Explore the relationship of MNSS with demographic variables (e.g.: age, gender, education), clinical-therapeutic variables (e.g.: age of diagnosis, number of hospitalizations, medication, type of support) and psychosocial variables (e.g.: functionality, satisfaction and well-being, motor experiences);
3. Test a multifactorial model of the relationships between MNSS, demographic variables, functional clinical-therapeutic and psychosocial;
4. Compare MNSS in people with schizophrenia and people from a healthy control group.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Motor Neurological Soft Signs
motor test and an interview for the participants
Brief Motor Scale_portuguese version (BMS_pt)
translate, adapt and validate Brief Motor Scale for portuguese population with schizophrenia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Brief Motor Scale_portuguese version (BMS_pt)
translate, adapt and validate Brief Motor Scale for portuguese population with schizophrenia
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Drugs consumer
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Faculdade de Motricidade Humana
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Susana Guimarães, MD
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Susana Guimarães, MD
Role: PRINCIPAL_INVESTIGATOR
Faculdade Motricidade Humana
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Susana Guimarães
Lisbon, , Portugal
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Validity and Reliability of the Portuguese Version of Brief Motor Scale in Persons with Schizophrenia: A Preliminary Study
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
32/2017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.